Market Cap 4,000.00
Revenue (ttm) 15.30M
Net Income (ttm) -100.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -659.41%
Debt to Equity Ratio 0.00
Volume 5,000
Avg Vol 72,540
Day's Range N/A - N/A
Shares Out 35.25M
Stochastic %K 0%
Beta 2.60
Analysts Strong Buy
Price Target $0.63

Company Profile

DermTech, Inc., a molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scal...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 858 450 4222
Fax: 858 200 3877
Address:
12340 El Camino Real, San Diego, United States
Latest News on DMTKQ
No data available.